Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin Ho

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Plos One|August 20, 2020
Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series studyAlvin Ho-Ting Li, Karen S Palmer, Monica Taljaard, et al.
Cancers|October 29, 2020
Transforming Growth Factor-β: A Multifunctional Regulator of Cancer ImmunityVivian Weiwen Xue, Jeff Yat-Fai Chung, Cristina Alexandra García Córdoba, et al.
Gut|April 10, 2024
<i>Lactococcus lactis HkyuLL 10</i> suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidaseAnthony Chin Yang Su, Xiao Ding, Harry Cheuk Hay Lau, et al.
Pathology|February 27, 2024
SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significantAlvin Ho-Kwan Cheung, Kit-Yee Wong, Shuk-Ling Chau, et al.
Cell Host & Microbe|July 26, 2024
Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPKPingmei Huang, Fenfen Ji, Alvin Ho-Kwan Cheung, et al.
International Journal of Molecular Sciences|May 27, 2017
Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal CarcinogenesisAlvin Ho-Kwan Cheung, Deepak Narayanan Iyer, Colin Siu-Chi Lam, et al.
Cell Host & Microbe|April 16, 2025
Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPKPingmei Huang, Fenfen Ji, Alvin Ho-Kwan Cheung, et al.
Cell Reports. Medicine|August 16, 2023
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapyYasi Pan, Huarong Chen, Xiang Zhang, et al.
Signal Transduction and Targeted Therapy|December 21, 2025
YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancerHenley Cheung, Huarong Chen, Danyu Chen, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 8, 2017
Systematic Review of Guidelines on Managing Patients with Harmful Use of Alcohol in Primary Healthcare SettingsDe-Xing Zhang, Shannon Tsz-Shan Li, Queenie Kwan-Yee Lee, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Plos One|August 20, 2020
Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series studyAlvin Ho-Ting Li, Karen S Palmer, Monica Taljaard, et al.
Cancers|October 29, 2020
Transforming Growth Factor-β: A Multifunctional Regulator of Cancer ImmunityVivian Weiwen Xue, Jeff Yat-Fai Chung, Cristina Alexandra García Córdoba, et al.
Gut|April 10, 2024
<i>Lactococcus lactis HkyuLL 10</i> suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidaseAnthony Chin Yang Su, Xiao Ding, Harry Cheuk Hay Lau, et al.
Pathology|February 27, 2024
SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significantAlvin Ho-Kwan Cheung, Kit-Yee Wong, Shuk-Ling Chau, et al.
Cell Host & Microbe|July 26, 2024
Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPKPingmei Huang, Fenfen Ji, Alvin Ho-Kwan Cheung, et al.
International Journal of Molecular Sciences|May 27, 2017
Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal CarcinogenesisAlvin Ho-Kwan Cheung, Deepak Narayanan Iyer, Colin Siu-Chi Lam, et al.
Cell Host & Microbe|April 16, 2025
Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPKPingmei Huang, Fenfen Ji, Alvin Ho-Kwan Cheung, et al.
Cell Reports. Medicine|August 16, 2023
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapyYasi Pan, Huarong Chen, Xiang Zhang, et al.
Signal Transduction and Targeted Therapy|December 21, 2025
YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancerHenley Cheung, Huarong Chen, Danyu Chen, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 8, 2017
Systematic Review of Guidelines on Managing Patients with Harmful Use of Alcohol in Primary Healthcare SettingsDe-Xing Zhang, Shannon Tsz-Shan Li, Queenie Kwan-Yee Lee, et al.
Pageof 7